PD-0745 Outcomes & predictors of progression: SBRT for lymph node oligorecurrent prostate cancer on PSMA-PET. (August 2021) - Werensteijn-Honingh, A.; Wevers, A.; Peters, M.; Kroon, P.; Intven, M.; Eppinga, W.; Jürgenliemk-Schulz, I.